Association of endothelial nitric oxide synthase gene polymorphisms with endometrial carcinoma: A preliminary study;Endometrium Kanseri Ile Endotelyal Nitrik Oksit Sentetaz Gen Polimorfizmi Arasındaki Ilişki: Pilot Çalışma

Journal of the Turkish German Gynecology Association

Volumn 12, Issue 4, 2011, Pages 229-233

  Öztürk, Ebru ^a   Dikensoy, Ebru ^a   Balat, Özcan ^a   Uǧur, Mete Gürol ^a   Balci, Sibel Oǧuzkan ^a   Aydin, Abdullah ^a   Kazanci, Ülkü ^a   Pehlivan, Sacide ^a  

^a GAZIANTEP UNIVERSITY   (Turkey)

Author keywords

Endometrial carcinoma; eNOS gene polymorphisms

Indexed keywords

GENOMIC DNA;

ADULT; ARTICLE; CANCER RISK; CONTROLLED STUDY; ENDOMETRIUM CANCER; ENDOMETRIUM CARCINOMA; ENDOTHELIAL NITRIC OXIDE SYNTHASE GENE; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; HUMAN TISSUE; HYSTERECTOMY; INTRON; MAJOR CLINICAL STUDY; ONCOGENE; RETROSPECTIVE STUDY; VARIABLE NUMBER OF TANDEM REPEAT;

EID: 82555197017     PISSN: 13090399     EISSN: 13090380     Source Type: Journal    
DOI: 10.5152/jtgga.2011.47     Document Type: Article

References (31)

1. Amant F, Moerman P, Neven P, Timmerman D, Van Limbergen E, Vergote I. Endometrial cancer. Lancet 2005; 366: 491-505. [CrossRef]
2. Meydanli{dotless} M, Karadag N, Kose F, Tulunay G, Ozfuttu A. Body Mass Index is Associated with Immunohistochemical Nuclear Phosphatase and Tensin Homolog Deleted on Chromosome 10 (PTEN) Expression in Stage IB-IC Endometrioid Endometrial Carcinoma. J Turkish-German Gynecol Assoc 2007; 8: 408-14.
3. Ozler A, Kuscu NK, Temiz P, Kandiloglu AR, Koyuncu FM. Leptin expression in proliferative, secretory and hyperplastic endometrial tissues. J Turkish-German Gynecol Assoc 2011; 12: 157-61. [CrossRef]
4. Ozturk HB, Vural B, Caliskan E, Solakoglu S. Effect of GnRH analogues and octreotide treatment on apoptosis and the cell proliferation of endometrium adenocarcinoma cell lines. J Turkish-German Gynecol Assoc 2010; 11: 131-6. [CrossRef]
5. Marsden PA, Heng HH, Scherer SW, Stewart RJ, Hall AV, Shi XM, et al. Structure and chromosomal localization of the human constitutive endothelial nitric oxide synthase gene. J Biol Chem 1993; 268: 17478-88.
6. Hingorani AD. Polymorphisms in endothelial nitric oxide synthase and atherogenesis: John French Lecture 2000. Atherosclerosis 2001; 154: 521-7. [CrossRef]
7. Mirvish SS. Role of N-nitroso compounds (NOC) and N-nitrosation in etiology of gastric, esophageal, nasopharyngeal and bladder cancer and contribution to cancer of known exposures to NOC. Cancer Lett 1995; 93: 17-48. [CrossRef]
8. Bentz BG, Barnes MN, Haines GK, Lurain JR, Hanson DG, Radosevich JA. Cytoplasmic localization of endothelial constitutive nitric oxide synthase in endometrial carcinomas. Tumour Biol 1997; 18: 290-300. [CrossRef]
9. Charles IG, Scorer CA, Moro MA, Fernàndez C, Chubb A, Dawson J, et al. Expression of human nitric oxide synthase isozymes. Methods Enzymol 1996; 268: 449-60. [CrossRef]
10. Riener EK, Hefler LA, Grimm C, Galid A, Zeillinger R, Tong-Cacsire D, et al. Polymorphisms of the endothelial nitric oxide synthase gene in women with vulvar cancer. Gynecol Oncol 2004; 93: 686-90. [CrossRef]
11. Hao Y, Montiel R, Huang Y. Endothelial nitric oxide synthase (eNOS) 894 G>T polymorphism is associated with breast cancer risk: a meta-analysis. Breast Cancer Res Treat 2010; 124: 809-13. [CrossRef]
12. Lee KM, Kang D, Park SK, Berndt SI, Reding D, Chatterjee N, et al. Nitric oxide synthase gene polymorphisms and prostate cancer risk. Carcinogenesis 2009; 30: 621-5. [CrossRef]
13. Yeh CC, Santella RM, Hsieh LL, Sung FC, Tang R. An intron 4 VNTR polymorphism of the endothelial nitric oxide synthase gene is associated with early-onset colorectal cancer. Int J Cancer 2009; 124: 1565-71. [CrossRef]
14. Meyer LA, Westin SN, Lu KH, Milam MR. Genetic polymorphisms and endometrial cancer risk. Expert Rev Anticancer Ther 2008; 8: 1159-67. [CrossRef]
15. Esinler I, Aktas D, Alikasifoglu M, Tuncbilek E, Ayhan A. CYP1A1 gene polymorphism and risk of endometrial hyperplasia and endometrial carcinoma. Int J Gynecol Cancer 2006; 16: 1407-11. [CrossRef]
16. Junqueira MG, da Silva ID, Nogueira-de-Souza NC, Carvalho CV, Leite DB, Gomes MT, et al. Progesterone receptor (PROGINS) polymorphism and the risk of endometrial cancer development. Int J Gynecol Cancer 2007; 17: 229-32. [CrossRef]
17. Xu L, Hu Y, Chen B, Tang W, Han X, Yu H, et al. Mitochondrial polymorphisms as risk factors for endometrial cancer in southwest China. Int J Gynecol Cancer 2006; 16: 1661-7. [CrossRef]
18. Saffari B, Bernstein L, Hong DC, Sullivan-Halley J, Runnebaum IB, Grill HJ, et al. Association of p53 mutations and a codon 72 single nucleotide polymorphism with lower overall survival and responsiveness to adjuvant radiotherapy in endometrioid endometrial carcinomas. Int J Gynecol Cancer 2005; 15: 952-63. [CrossRef]
19. Casas JP, Cavalleri GL, Bautista LE, Smeeth L, Humphries SE, Hingorani AD. Endothelial nitric oxide synthase gene polymorphisms and cardiovascular disease: a HuGE review. Am J Epidemiol 2006; 164: 921-35. [CrossRef]
20. Mikuta JJ. International Federation of Gynecologic and Obstetrics staging of endometrial cancer. Cancer 1988; 71: 1460-3. [CrossRef]
21. Erciyas K, Pehlivan S, Sever T, Igci M, Pehlivan M, Arslan A, et al. Endothelial nitric oxide synthase gene polymorphisms associated with periodontal diseases in Turkish adults. African J Biotechnology 2010; 9: 3042-7.
22. Erciyas K, Pehlivan S, Sever T, et al. Endothelial nitric oxide synthase gene polymorphisms associated with periodontal diseases in Turkish adults. African J Biotechnology 2010; 9: 3042-7.
23. Mendell NR, Simon GA. A general expression for the variance-covariance matrix of estimates of gene frequency: the effects of departures from Hardy-Weinberg equilibrium. Ann Hum Genet 1984; 48: 283-6. [CrossRef]
24. Turan AT, Dundar B, Gundogdu B, Boztosun A, Özgül N, Boran N, et al. The effect of cell type on surgico-pathologic risk factors in endometrial cancer. J Turkish-German Gynecol Assoc 2011; 12: 9-14. [CrossRef]
25. Turan T, Ortac F, Güngör M, Heper A, Ensari A. Angiogenesis is not a prognostic marker in endometrial carcinoma. J Turkish-German Gynecol Assoc 2000; 1: 13-6.
26. Emons G, Fleckenstein G, Hinney B, Huschmand A, Heyl W. Hormonal interactions in endometrial cancer. Endocr Relat Cancer 2000; 7: 227-42. [CrossRef]
27. Duckles SP, Miller VM. Hormonal modulation of endothelial NO production. Pflugers Arch 2010; 459: 841-51. [CrossRef]
28. Singh S, Gupta AK. Nitric oxide: role in tumour biology and iNOS/NO-based anticancer therapies. Cancer Chemother Pharmacol 2011; 67: 1211-24. [CrossRef]
29. Cheon KT, Choi KH, Lee HB, Park SK, Rhee YK, Lee YC. Gene polymorphisms of endothelial nitric oxide synthase and angiotensin-converting enzyme in patients with lung cancer. Lung 2000; 178: 351-60. [CrossRef]
30. Ghilardi G, Biondi ML, Cecchini F, DeMonti M, Guagnellini E, Scorza R. Vascular invasion in human breast cancer is correlated to T-786C polymorphism of NOS3 gene. Nitric Oxide 2003; 9: 118-22. [CrossRef]
31. Mozet C, Marin DG, Bertolini J, Tannapfel A, Wichmann G, Dietz A. Nitric oxide synthase (NOS2/3) expression in head and neck squamous cell carcinomas in correlation with clinical patterns. Onkologie 2009; 32: 655-60. [CrossRef]